Radiation Oncology Market Forecast and Regional Share 2031
The radiation oncology market size is projected to reach US$ 23,620.56 million by 2031 from US$ 8,924.44 million in 2023. The market is expected to register a CAGR of 13.0% in 2023–2031. Technological advancements in radiation oncology are likely to bring key trends in the market in the coming years.
Radiation Oncology Market Analysis
Governments and private entities are investing in healthcare infrastructure, including radiation therapy centers, to enhance service quality and availability. Thus, the radiation oncology market is driven by initiatives to support developments in radiation oncology for better and effective patient outcomes, along with the increasing prevalence of cancer. Moreover, companies in the radiation oncology market engage in product launches, product approvals, partnerships, mergers and acquisitions, which are expected to create ample opportunities in the market in the coming years.
Radiation Oncology Market Overview
Radiation oncology is one of the fastest-developing cancer treatment modalities. Technological advancements and increasing awareness among large populations are among the major factors contributing to the radiation oncology market growth. North America dominates the radiation oncology market, and Asia Pacific is expected to register the highest CAGR during the forecast period. Market growth in Asia Pacific is attributed to the presence of developing economies that hold ample growth opportunities. Cancer has quickly become a public health concern in India. Approximately 1.39 million cancer cases were reported in the country in 2020. The disease was also ranked among the world's leading causes of death in 2020, accounting for approximately 10 million deaths. To combat cancer more successfully, the Government of India has implemented several initiatives that focus on investing resources in building adequate infrastructure for cancer care as well as in implementing mass-scale programs for prevention, control, and screening of common cancer types.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Radiation Oncology Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Radiation Oncology Market: Strategic Insights
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Radiation Oncology Market Drivers and Opportunities
Increasing Prevalence of Cancer Favor Radiation Oncology Market
Cancer is one of the common health conditions significantly impacting societies worldwide. According to the World Health Organization (WHO), it is the leading cause of death across the world; it was the cause of 20 million new cancer cases and 9.7 million deaths in 2022. The number of new cancer cases is expected to reach ~35 million new cancer cases by 2050. As per the WHO 2024 report, lung cancer is the most common cancer cause of mortality globally, followed by colorectal cancer, liver cancer, breast cancer, and stomach cancer, which are responsible for 18.7%, 9.3%, 7.8%, 6.9%, and 6.8% of the total cancer related deaths, respectively. The incidences of the top 10 cancer types are mentioned in the table below:
Statistics at Glance, Global, 2022
Cancer | Total New Cases, 2022 |
Lung | 2 480 675 |
Breast | 2 296 840 |
Colorectum | 1 926 425 |
Prostate | 1 467 854 |
Stomach | 968 784 |
Liver | 866 136 |
Thyroid | 821 214 |
Cervix Uteri | 662 301 |
Bladder | 614 298 |
NHL | 553 389 |
Source: Global Cancer Observatory
The increasing incidence of cancer results in a huge demand for effective treatment options. Radiotherapy is one of the continuously evolving treatment options with effective outcomes for cancer patients. The method of intervention utilizes high doses of radiation such as X-rays and gamma rays to kill cancer cells. Radiation therapy is mainly prescribed in patients with the early stages of cancer, while it can be used at any point in the treatment. Various types of external beam radiotherapy are used for the treatment of different cancer types. For instance, brachytherapy is used for the treatment of breast cancer, cervix cancer, eye cancer, prostate cancer, and head & neck cancer. Further, systemic radiation therapy, also known as radioactive iodine therapy, is used for the treatment of thyroid cancer. Thus, the increasing prevalence of cancer and the evolution of radiotherapy in oncology bolsters the radiation oncology market growth.
Strategic Initiatives to Create Opportunities for Radiation Oncology Market Growth
Companies in the radiation oncology market are making continuous efforts in terms of product developments, innovations, launches, and approvals; mergers; acquisitions; and partnerships to contribute to the evolution of radiotherapy. A few of the recent strategic initiatives that took place in the market in recent years are mentioned below.
- In May 2024, Elekta launched its latest linear accelerator (linac) named Evo. This computed tomography (CT) linac with new high-definition, AI-enhanced imaging is capable of delivering offline and online adaptive radiation therapy along with image-guided radiation therapy treatments with improved standards.
- In May 2024, the Icon Group collaborated with Cyberknife Australia Pty Ltd to establish up to 6 new radiation oncology clinics (proposed joint ventures) with the goal of providing radiation oncology treatments using the “Cyberknife” system.
- In May 2024, GE HealthCare launched Revolution RT, a new CT radiation therapy solution with innovative hardware and software offerings, to help enhance imaging accuracy while simplifying simulation workflow for a more personalized and seamless cancer care process for clinicians and patients.
- In April 2024, Accuray Incorporated showcased advancements in hardware and software designed to improve the cancer treatment experience at ESTRO 2024. The latest-generation CyberKnife and Radixact platforms provide medical care teams with the technology necessary for expanding the curative power of radiation therapy.
- In October 2023, CIVCO Radiotherapy and Qfix collaboratively launched a new brand CQ Medical. The company focuses on the improvement of cancer care and patient outcomes, with deep engagement in the field with clinicians and technology partners.
- In September 2023, MVision AI launched the first comprehensive Guideline-Based Segmentation (GBS) solution, harnessing the abilities of its Guide, Verify, and Contour+ offerings for effective radiation therapy contouring. The Guide facilitates clinical teams to accurately evaluate AI-generated structures, thus enabling them to refine their contouring skills. The Verify system allows the visual and volumetric comparison of contours, facilitating clinics to observe similarities and differences. The combined implementation of Guide, Verify, and Contour+ encompasses all clinical needs in radiotherapy contouring.
Therefore, strategic initiatives by market players operating in the radiation oncology market are expected to create ample opportunities for the radiation oncology market in the coming years
Radiation Oncology Market Report Segmentation Analysis
Key segments that contributed to the derivation of the radiation oncology analysis are type and application.
- Based on type, the radiation oncology market is bifurcated into external beam radiation therapy and internal beam radiation therapy. The external beam radiation therapy segment held a larger share of the market in 2023; however, internal beam radiation therapy is anticipated to register a higher CAGR during the forecast period.
- By application, the market is segmented into breast cancer, prostate cancer, lung cancer, head & neck cancer, cervical cancer, and others. The breast cancer segment held the largest share of the market in 2023; it is further anticipated to register the highest CAGR during 2023–2031.
Radiation Oncology Market Share Analysis by Geography
The geographic scope of the radiation oncology report is mainly divided into five regions: North America, Asia Pacific, Europe, the Middle East & Africa, and South & Central America. North America dominates the radiation oncology market, which can be attributed to the increasing prevalence of cancer along with technological advancement in the region. The US is expected to account for the dominating share of the market in this region. The number of professionals having radiation treatment expertise is also on the rise in the country, which can be attributed to the accessibility of a developed healthcare infrastructure. As per the American Society of Clinical Oncology, approximately two-thirds of cancer patients globally are estimated to receive radiation therapy as a part of their treatment. In 2022, over 1 million cancer patients in the US received radiation therapy. The government and healthcare authorities are taking several initiatives to encourage the adoption of radiotherapy. In June 2020, the American Society for Radiation Oncology (ASTRO) introduced new clinical guidelines regarding radiotherapy for nonmetastatic cervical cancer. The new guidelines focus on precisely implementing steps and processes to conduct radiation therapy. Asia Pacific is anticipated to record the highest CAGR during 2023–2031.
Radiation Oncology Market Report Scope
Radiation Oncology Market News and Recent Developments
The radiation oncology market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:
- Curium has submitted a new drug application (NDA) for its lutetium-177 (Lu-177) DOTATATE radiopharmaceutical for the treatment of somatostatin receptor-positive gastroenteropancreatic neuroendocrine tumors (GEP-NETS). The radiopharmaceutical is designed to be injected into patients to deliver Lu-177 radiation directly to tumors. (Curium, Company Website, July 2024)
- IBA has signed a contract with the Connecticut Proton Therapy Center, a collaboration between Yale New Haven Health, Hartford HealthCare, and Proton International, for the installation of a Proteus ONE compact proton therapy system. (IBA, Company Website, May 2024)
- Varian has received 510(k) clearance from the US Food and Drug Administration (FDA) and the CE mark in the European Union for Halcyon and Ethos radiotherapy systems featuring Varian's HyperSight imaging solution. HyperSight enables clinicians to capture high-quality images of patients during their daily radiation treatments. (Varian, Company Website, February 2024)
Radiation Oncology Market Report Coverage and Deliverables
The "Radiation Oncology Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:
- Radiation oncology market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Radiation oncology market trends as well as market dynamics such as drivers, restraints, and key opportunities
- Detailed PEST/Porter's Five Forces and SWOT analysis
- Radiation oncology market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
- Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the radiation oncology market
- Detailed company profiles
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
North America dominated the market in 2023.
The increasing prevalence of cancer and initiatives to support developments in radiation oncology are the pivotal factors fueling the market growth.
The estimated value of the market would be US$ 23,620.56 million by 2031.
Technological advancements are likely to bring attractive trends in the market in the coming years.
Varian Medical Systems Inc, Elekta AB, Accuracy Incorporated, IBA Worldwide (Ion Beam Applications SA), Becton Dickinson & Co, Perspective Therapeutics Inc, Nordion, Mevion Medical Systems, NTP Radioisotopes, and Mallinckrodt Plc are among the key players in the market.
The market is expected to register a CAGR of 13% during 2023–2031.
1. Introduction
1.1 The Insight Partners Research Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Insights
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
3.2.1 Hypothesis formulation:
3.2.2 Macro-economic factor analysis:
3.2.3 Developing base number:
3.2.4 Data Triangulation:
3.2.5 Country level data:
4. Radiation Oncology Market Landscape
4.1 Overview
4.2 PEST Analysis
5. Radiation Oncology Market – Key Market Dynamics
5.1 Radiation Oncology Market – Key Market Dynamics
5.2 Market Drivers:
5.2.1 Increasing Prevalence of Cancer
5.2.2 Initiatives to Support Developments in Radiation Oncology
5.3 Market Restraints
5.3.1 High Cost of Radiotherapy Equipment
5.4 Market Opportunities
5.4.1 Strategic Initiatives in Radiation Oncology
5.5 Future Trends
5.5.1 Technological Advancement in Radiation Oncology
5.6 Impact of Drivers and Restraints:
6. Radiation Oncology Market – Global Market Analysis
6.1 Radiation Oncology Market Revenue (US$ Million), 2021–2031
7. Radiation Oncology Market Analysis – by Types
7.1 External Beam Radiation Therapy
7.1.1 Overview
7.1.2 External Beam Radiation Therapy: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
7.2 Internal Beam Radiation Therapy
7.2.1 Overview
7.2.2 Internal Beam Radiation Therapy: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8. Radiation Oncology Market Analysis – by Application
8.1 Breast Cancer
8.1.1 Overview
8.1.2 Breast Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.2 Prostate Cancer
8.2.1 Overview
8.2.2 Prostate Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.3 Lung Cancer
8.3.1 Overview
8.3.2 Lung Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.4 Head and Neck Cancer
8.4.1 Overview
8.4.2 Head and Neck Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.5 Cervical Cancer
8.5.1 Overview
8.5.2 Cervical Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9. Radiation Oncology Market – Geographical Analysis
9.1 North America
9.1.1 North America Radiation Oncology Market Overview
9.1.2 North America: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.1.2.1 North America: Radiation Oncology Market – Revenue and Forecast Analysis – by Types
9.1.2.2 North America: Radiation Oncology Market – Revenue and Forecast Analysis – by External Beam Radiation Therapy
9.1.2.3 North America: Radiation Oncology Market – Revenue and Forecast Analysis – by Internal Beam Radiation Therapy
9.1.2.4 North America: Radiation Oncology Market – Revenue and Forecast Analysis – by Application
9.1.3 North America: Radiation Oncology Market – Revenue and Forecast Analysis – by Country
9.1.3.1 United States: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.1.3.1.1 United States: Radiation Oncology Market Breakdown, by Types
9.1.3.1.2 United States: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.3.1.3 United States: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.3.1.4 United States: Radiation Oncology Market Breakdown, by Application
9.1.3.2 Canada: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.1.3.2.1 Canada: Radiation Oncology Market Breakdown, by Types
9.1.3.2.2 Canada: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.3.2.3 Canada: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.3.2.4 Canada: Radiation Oncology Market Breakdown, by Application
9.1.3.3 Mexico: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.1.3.3.1 Mexico: Radiation Oncology Market Breakdown, by Types
9.1.3.3.2 Mexico: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.1.3.3.3 Mexico: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.1.3.3.4 Mexico: Radiation Oncology Market Breakdown, by Application
9.2 Europe
9.2.1 Europe Radiation Oncology Market Overview
9.2.2 Europe: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.2.1 Europe: Radiation Oncology Market – Revenue and Forecast Analysis – by Types
9.2.2.2 Europe: Radiation Oncology Market – Revenue and Forecast Analysis – by External Beam Radiation Therapy
9.2.2.3 Europe: Radiation Oncology Market – Revenue and Forecast Analysis – by Internal Beam Radiation Therapy
9.2.2.4 Europe: Radiation Oncology Market – Revenue and Forecast Analysis – by Application
9.2.3 Europe: Radiation Oncology Market – Revenue and Forecast Analysis – by Country
9.2.3.1 Germany: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.1.1 Germany: Radiation Oncology Market Breakdown, by Types
9.2.3.1.2 Germany: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.1.3 Germany: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.1.4 Germany: Radiation Oncology Market Breakdown, by Application
9.2.3.2 United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.2.1 United Kingdom: Radiation Oncology Market Breakdown, by Types
9.2.3.2.2 United Kingdom: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.2.3 United Kingdom: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.2.4 United Kingdom: Radiation Oncology Market Breakdown, by Application
9.2.3.3 France: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.3.1 France: Radiation Oncology Market Breakdown, by Types
9.2.3.3.2 France: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.3.3 France: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.3.4 France: Radiation Oncology Market Breakdown, by Application
9.2.3.4 Spain: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.4.1 Spain: Radiation Oncology Market Breakdown, by Types
9.2.3.4.2 Spain: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.4.3 Spain: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.4.4 Spain: Radiation Oncology Market Breakdown, by Application
9.2.3.5 Italy: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.5.1 Italy: Radiation Oncology Market Breakdown, by Types
9.2.3.5.2 Italy: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.5.3 Italy: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.5.4 Italy: Radiation Oncology Market Breakdown, by Application
9.2.3.6 Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.2.3.6.1 Rest of Europe: Radiation Oncology Market Breakdown, by Types
9.2.3.6.2 Rest of Europe: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.2.3.6.3 Rest of Europe: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.2.3.6.4 Rest of Europe: Radiation Oncology Market Breakdown, by Application
9.3 Asia Pacific
9.3.1 Asia Pacific Radiation Oncology Market Overview
9.3.2 Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.2.1 Asia Pacific: Radiation Oncology Market – Revenue and Forecast Analysis – by Types
9.3.2.2 Asia Pacific: Radiation Oncology Market – Revenue and Forecast Analysis – by External Beam Radiation Therapy
9.3.2.3 Asia Pacific: Radiation Oncology Market – Revenue and Forecast Analysis – by Internal Beam Radiation Therapy
9.3.2.4 Asia Pacific: Radiation Oncology Market – Revenue and Forecast Analysis – by Application
9.3.3 Asia Pacific: Radiation Oncology Market – Revenue and Forecast Analysis – by Country
9.3.3.1 China: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.1.1 China: Radiation Oncology Market Breakdown, by Types
9.3.3.1.2 China: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.1.3 China: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.1.4 China: Radiation Oncology Market Breakdown, by Application
9.3.3.2 Japan: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.2.1 Japan: Radiation Oncology Market Breakdown, by Types
9.3.3.2.2 Japan: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.2.3 Japan: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.2.4 Japan: Radiation Oncology Market Breakdown, by Application
9.3.3.3 India: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.3.1 India: Radiation Oncology Market Breakdown, by Types
9.3.3.3.2 India: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.3.3 India: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.3.4 India: Radiation Oncology Market Breakdown, by Application
9.3.3.4 Australia: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.4.1 Australia: Radiation Oncology Market Breakdown, by Types
9.3.3.4.2 Australia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.4.3 Australia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.4.4 Australia: Radiation Oncology Market Breakdown, by Application
9.3.3.5 South Korea: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.5.1 South Korea: Radiation Oncology Market Breakdown, by Types
9.3.3.5.2 South Korea: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.5.3 South Korea: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.5.4 South Korea: Radiation Oncology Market Breakdown, by Application
9.3.3.5.5 Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.3.3.5.6 Rest of APAC: Radiation Oncology Market Breakdown, by Types
9.3.3.5.7 Rest of APAC: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.3.3.5.8 Rest of APAC: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.3.3.5.9 Rest of APAC: Radiation Oncology Market Breakdown, by Application
9.4 Middle East and Africa
9.4.1 Middle East and Africa Radiation Oncology Market Overview
9.4.2 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.4.2.1 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast Analysis – by Types
9.4.2.2 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast Analysis – by External Beam Radiation Therapy
9.4.2.3 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast Analysis – by Internal Beam Radiation Therapy
9.4.2.4 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast Analysis – by Application
9.4.3 Middle East and Africa: Radiation Oncology Market – Revenue and Forecast Analysis – by Country
9.4.3.1 Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.4.3.1.1 Saudi Arabia: Radiation Oncology Market Breakdown, by Types
9.4.3.1.2 Saudi Arabia: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.4.3.1.3 Saudi Arabia: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.4.3.1.4 Saudi Arabia: Radiation Oncology Market Breakdown, by Application
9.4.3.2 South Africa: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.4.3.2.1 South Africa: Radiation Oncology Market Breakdown, by Types
9.4.3.2.2 South Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.4.3.2.3 South Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.4.3.2.4 South Africa: Radiation Oncology Market Breakdown, by Application
9.4.3.3 United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.4.3.3.1 United Arab Emirates: Radiation Oncology Market Breakdown, by Types
9.4.3.3.2 United Arab Emirates: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.4.3.3.3 United Arab Emirates: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.4.3.3.4 United Arab Emirates: Radiation Oncology Market Breakdown, by Application
9.4.3.4 Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.4.3.4.1 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Types
9.4.3.4.2 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.4.3.4.3 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.4.3.4.4 Rest of Middle East and Africa: Radiation Oncology Market Breakdown, by Application
9.5 South and Central America
9.5.1 South and Central America Radiation Oncology Market Overview
9.5.2 South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.5.2.1 South and Central America: Radiation Oncology Market – Revenue and Forecast Analysis – by Types
9.5.2.2 South and Central America: Radiation Oncology Market – Revenue and Forecast Analysis – by External Beam Radiation Therapy
9.5.2.3 South and Central America: Radiation Oncology Market – Revenue and Forecast Analysis – by Internal Beam Radiation Therapy
9.5.2.4 South and Central America: Radiation Oncology Market – Revenue and Forecast Analysis – by Application
9.5.3 South and Central America: Radiation Oncology Market – Revenue and Forecast Analysis – by Country
9.5.3.1 Brazil: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.5.3.1.1 Brazil: Radiation Oncology Market Breakdown, by Types
9.5.3.1.2 Brazil: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.5.3.1.3 Brazil: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.5.3.1.4 Brazil: Radiation Oncology Market Breakdown, by Application
9.5.3.2 Argentina: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.5.3.2.1 Argentina: Radiation Oncology Market Breakdown, by Types
9.5.3.2.2 Argentina: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.5.3.2.3 Argentina: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.5.3.2.4 Argentina: Radiation Oncology Market Breakdown, by Application
9.5.3.3 Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
9.5.3.3.1 Rest of South and Central America: Radiation Oncology Market Breakdown, by Types
9.5.3.3.2 Rest of South and Central America: Radiation Oncology Market Breakdown, by External Beam Radiation Therapy
9.5.3.3.3 Rest of South and Central America: Radiation Oncology Market Breakdown, by Internal Beam Radiation Therapy
9.5.3.3.4 Rest of South and Central America: Radiation Oncology Market Breakdown, by Application
10. Radiation Oncology Market – Industry Landscape
10.1 Overview
10.2 Growth Strategies in Radiation Oncology Market
10.3 Organic Growth Strategies
10.3.1 Overview
10.4 Inorganic Growth Strategies
10.4.1 Overview
11. Company Profiles
11.1 Varian Medical Systems Inc
11.1.1 Key Facts
11.1.2 Business Description
11.1.3 Products and Services
11.1.4 Financial Overview (Siemens Healthineers AG)
11.1.5 SWOT Analysis
11.1.6 Key Developments
11.2 Elekta AB
11.2.1 Key Facts
11.2.2 Business Description
11.2.3 Products and Services
11.2.4 Financial Overview
11.2.5 SWOT Analysis
11.2.6 Key Developments
11.3 Accuray Incorporated
11.3.1 Key Facts
11.3.2 Business Description
11.3.3 Products and Services
11.3.4 Financial Overview
11.3.5 SWOT Analysis
11.3.6 Key Developments
11.4 IBA Worldwide (Ion Beam Applications SA)
11.4.1 Key Facts
11.4.2 Business Description
11.4.3 Products and Services
11.4.4 Financial Overview
11.4.5 SWOT Analysis
11.4.6 Key Developments
11.5 Becton Dickinson and Co
11.5.1 Key Facts
11.5.2 Business Description
11.5.3 Products and Services
11.5.4 Financial Overview
11.5.5 SWOT Analysis
11.5.6 Key Developments
11.6 Perspective Therapeutics Inc
11.6.1 Key Facts
11.6.2 Business Description
11.6.3 Products and Services
11.6.4 Financial Overview
11.6.5 SWOT Analysis
11.6.6 Key Developments
11.7 Nordion
11.7.1 Key Facts
11.7.2 Business Description
11.7.3 Products and Services
11.7.4 Financial Overview
11.7.5 SWOT Analysis
11.7.6 Key Developments
11.8 Mevion Medical Systems
11.8.1 Key Facts
11.8.2 Business Description
11.8.3 Products and Services
11.8.4 Financial Overview
11.8.5 SWOT Analysis
11.8.6 Key Developments
11.9 NTP RADIOISOTOPES
11.9.1 Key Facts
11.9.2 Business Description
11.9.3 Products and Services
11.9.4 Financial Overview
11.9.5 SWOT Analysis
11.9.6 Key Developments
11.10 Mallinckrodt Plc
11.10.1 Key Facts
11.10.2 Business Description
11.10.3 Products and Services
11.10.4 Financial Overview
11.10.5 SWOT Analysis
11.10.6 Key Developments
11.11 Provision Healthcare
11.11.1 Key Facts
11.11.2 Business Description
11.11.3 Products and Services
11.11.4 Financial Overview
11.11.5 SWOT Analysis
11.11.6 Key Developments
11.12 Panacea Medical Technologies Pvt. Ltd
11.12.1 Key Facts
11.12.2 Business Description
11.12.3 Products and Services
11.12.4 Financial Overview
11.12.5 SWOT Analysis
11.12.6 Key Developments
11.13 Curium
11.13.1 Key Facts
11.13.2 Business Description
11.13.3 Products and Services
11.13.4 Financial Overview
11.13.5 SWOT Analysis
11.13.6 Key Developments
12. Appendix
12.1 About The Insight Partners
12.2 Glossary of Terms
List of Tables
Table 1. Radiation Oncology Market Segmentation
Table 2. North America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 3. North America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 4. North America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 5. North America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 6. United States: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 7. United States: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 8. United States: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 9. United States: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 10. Canada: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 11. Canada: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 12. Canada: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 13. Canada: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 14. Mexico: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 15. Mexico: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 16. Mexico: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 17. Mexico: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 18. Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 19. Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 20. Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 21. Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 22. Germany: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 23. Germany: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 24. Germany: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 25. Germany: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 26. United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 27. United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 28. United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 29. United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 30. France: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 31. France: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 32. France: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 33. France: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 34. Spain: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 35. Spain: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 36. Spain: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 37. Spain: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 38. Italy: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 39. Italy: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 40. Italy: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 41. Italy: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 42. Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 43. Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 44. Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 45. Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 46. Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 47. Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 48. Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 49. Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 50. China: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 51. China: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 52. China: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 53. China: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 54. Japan: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 55. Japan: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 56. Japan: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 57. Japan: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 58. India: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 59. India: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 60. India: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 61. India: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 62. Australia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 63. Australia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 64. Australia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 65. Australia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 66. South Korea: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 67. South Korea: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 68. South Korea: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 69. South Korea: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 70. Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 71. Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 72. Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 73. Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 74. Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 75. Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 76. Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 77. Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 78. Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 79. Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 80. Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 81. Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 82. South Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 83. South Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 84. South Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 85. South Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 86. United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 87. United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 88. United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 89. United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 90. Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 91. Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 92. Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 93. Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 94. South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 95. South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 96. South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 97. South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 98. Brazil: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 99. Brazil: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 100. Brazil: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 101. Brazil: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 102. Argentina: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 103. Argentina: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 104. Argentina: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 105. Argentina: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 106. Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Types
Table 107. Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by External Beam Radiation Therapy
Table 108. Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Internal Beam Radiation Therapy
Table 109. Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million) – by Application
Table 110. Recent Organic Growth Strategies in Radiation Oncology Market
Table 111. Recent Inorganic Growth Strategies in the Radiation Oncology Market
Table 112. Glossary of Terms, Radiation Oncology Market
List of Figures
Figure 1. Radiation Oncology Market Segmentation, by Geography
Figure 2. PEST Analysis
Figure 3. Statistics at Glance, Global, 2022
Figure 4. Impact Analysis of Drivers and Restraints
Figure 5. Radiation Oncology Market Revenue (US$ Million), 2021–2031
Figure 6. Radiation Oncology Market Share (%) – by Types (2023 and 2031)
Figure 7. External Beam Radiation Therapy: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 8. Internal Beam Radiation Therapy: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 9. Radiation Oncology Market Share (%) – by Application (2023 and 2031)
Figure 10. Breast Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 11. Prostate Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 12. Lung Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 13. Head and Neck Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 14. Cervical Cancer: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 15. Others: Radiation Oncology Market – Revenue and Forecast to 2031 (US$ Million)
Figure 16. North America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 17. North America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 18. United States: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 19. Canada: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 20. Mexico: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 21. Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 22. Europe: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 23. Germany: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 24. United Kingdom: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 25. France: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 26. Spain: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 27. Italy: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 28. Rest of Europe: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 29. Asia Pacific: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 30. Asia Pacific: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 31. China: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 32. Japan: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 33. India: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 34. Australia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 35. South Korea: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 36. Rest of APAC: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 37. Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 38. Middle East and Africa: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 39. Saudi Arabia: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 40. South Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 41. United Arab Emirates: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 42. Rest of Middle East and Africa: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 43. South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 44. South and Central America: Radiation Oncology Market Breakdown, by Key Countries, 2023 and 2031 (%)
Figure 45. Brazil: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 46. Argentina: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 47. Rest of South and Central America: Radiation Oncology Market – Revenue and Forecast to 2031(US$ Million)
Figure 48. Growth Strategies in Radiation Oncology Market
The List of Companies - Radiation Oncology Market
- Varian Medical Systems Inc
- Elekta AB
- Accuracy Incorporated
- IBA Worldwide (Ion Beam Applications SA)
- Becton Dickinson & Co
- Perspective Therapeutics Inc
- Nordion
- Mevion Medical Systems
- NTP Radioisotopes
- Mallinckrodt Plc
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Get Free Sample For